SNT-207707
|
|
|
- CAS号:
- 1064662-40-3
- 英文名:
- SNT-207707
- 英文别名:
- SNT-207707;SNT207707,SNT 207707;FBNJDWPWZNPVSC-UHFFFAOYSA-N;IMidazo[1,2-a]pyridine-6-carboxaMide, 2-(4-cyanophenyl)-N,N-bis(3-Methylbutyl)-3-[3-(1-pyrrolidinyl)propyl]-, hydrochloride (1:1)
- 中文名:
- SNT-207707
- 中文别名:
- 化合物 T12944
- CBNumber:
- CB82628406
- 分子式:
- C32H44ClN5O
- 分子量:
- 550.19
- MOL File:
- 1064662-40-3.mol
|
|
|
SNT-207707化学性质
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO: ≥ 250 mg/mL (454.40 mM); Methanol: 250 mg/mL (454.40 mM)
-
|
SNT-207707性质、用途与生产工艺
SNT-207707是一种有效，选择性，有口服活性的黑素皮质素受体 (melanocortin MC-4) 拮抗剂，IC50 值为8 nM (结合) 和5 nM (功能)。
IC50: 8 nM (binding MC-4), 5 nM (function MC-4)
SNT-207707 binds to the MC-4 receptor with an affinity of 8 nM and shows a more than 200-fold selectivity vs. MC-3 and MC-5. SNT207858 is a 22 nM MC-4 antagonist with a 170-fold selectivity vs. MC-3 and a 40-fold selectivity versus MC-5.
Single subcutaneous injection of 20 mg/kg of SNT-207707 distinctly increases food intake of the mice. Once daily oral administration of both compounds SNT207858 and SNT-207707 starting the day after tumor implantation significantly reduces the tumor induced weight loss.
SNT-207707
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/04/30 | HY-11029 | SNT-207707 | | 1 mg | 1363元 |
| 2024/04/30 | HY-11029 | SNT-207707
SNT-207707 | 1064662-40-3 | 5mg | 3000元 |
1064662-40-3, SNT-207707 相关搜索:
- 化合物 T12944
- 1064662-40-3
- SNT207707,SNT 207707
- FBNJDWPWZNPVSC-UHFFFAOYSA-N
- IMidazo[1,2-a]pyridine-6-carboxaMide, 2-(4-cyanophenyl)-N,N-bis(3-Methylbutyl)-3-[3-(1-pyrrolidinyl)propyl]-, hydrochloride (1:1)
- SNT-207707